Tackling Nonatrial Fibrillation Diseases Using Nonvitamin K Antagonist Oral Anticoagulant: by What and for Whom?

被引：0
|
作者：
Kim, Jong S. [1 ]
机构：
[1] Univ Ulsan, Dept Neurol, Asan Med Ctr, Coll Med, 88 Olymp Ro,43 Gil, Seoul 05505, South Korea
来源：
JOURNAL OF STROKE | 2019年 / 21卷 / 03期
关键词：
D O I：
10.5853/jos.2019.02474
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：241 / 241
页数：1
相关论文
共 50 条
  • [31] Nonvitamin K Oral Anticoagulants in Patients With Atrial Fibrillation and Severe Renal Dysfunction
    Mahmood, Maria
    Lip, Gregory Y. H.
    REVISTA ESPANOLA DE CARDIOLOGIA, 2018, 71 (10): : 847 - 855
  • [32] Inappropriate dose of nonvitamin-K antagonist oral anticoagulants: prevalence and impact on clinical outcome in patients with nonvalvular atrial fibrillation
    Godino, Cosmo
    Bodega, Francesca
    Melillo, Francesco
    Rubino, Francesca
    Parlati, Antonio L. M.
    Cappelletti, Alberto
    Mazzone, Patrizio
    Mattiello, Paolo
    Della Bella, Paolo
    Castiglioni, Alessandro
    Alfieri, Ottavio
    De Bonis, Michele
    Montorfano, Matteo
    Tresoldi, Moreno
    Filippi, Massimo
    Zangrillo, Alberto
    Salerno, Anna
    Cera, Michela
    Margonato, Alberto
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2020, 21 (10) : 751 - 758
  • [33] Adherence to oral anticoagulant therapy in patients with atrial fibrillation Focus on non-vitamin K antagonist oral anticoagulants
    Raparelli, Valeria
    Proietti, Marco
    Cangemi, Roberto
    Lip, Gregory Y. H.
    Lane, Deirdre A.
    Basili, Stefania
    THROMBOSIS AND HAEMOSTASIS, 2017, 117 (02) : 209 - 218
  • [34] Comparing the Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants and Warfarin in Elderly Asian Patients With Atrial Fibrillation A Nationwide Cohort Study
    Chao, Tze-Fan
    Chiang, Chern-En
    Liao, Jo-Nan
    Chen, Tzeng-Ji
    Lip, Gregory Y. H.
    Chen, Shih-Ann
    CHEST, 2020, 157 (05) : 1266 - 1277
  • [35] Safety and efficacy of nonvitamin K antagonist oral anticoagulants during catheter ablation of atrial fibrillation: A systematic review and meta-analysis
    Ge, Zhen
    Faggioni, Michela
    Baber, Usman
    Sartori, Samantha
    Sorrentino, Sabato
    Farhan, Serdar
    Chandrasekhar, Jaya
    Vogel, Birgit
    Qadeer, Abdul
    Halperin, Jonathan
    Reddy, Vivek
    Dukkipati, Srinivas
    Dangas, George
    Mehran, Roxana
    CARDIOVASCULAR THERAPEUTICS, 2018, 36 (05)
  • [36] Non-vitamin K antagonist oral anticoagulant dosing in patients with atrial fibrillation and renal dysfunction
    Khan, Ahsan A.
    Lip, Gregory Y. H.
    ANNALS OF TRANSLATIONAL MEDICINE, 2017, 5 (23)
  • [37] Non-Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction
    Yao, Xiaoxi
    Shah, Nilay D.
    Sangaralingham, Lindsey R.
    Gersh, Bernard J.
    Noseworthy, Peter A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (23) : 2779 - 2790
  • [38] Clopidogrel response in patients receiving the nonvitamin K antagonist oral anticoagulants apixaban and rivaroxaban
    Gosetti, Rosanna
    Sarafoff, Nikolaus
    Laugwitz, Karl-Ludwig
    Kastrati, Adnan
    Bernlochner, Isabell
    Goedel, Alexander
    CORONARY ARTERY DISEASE, 2021, 32 (02) : 167 - 169
  • [39] Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naive atrial fibrillation patients
    Larsen, Torben Bjerregaard
    EUROPACE, 2015, 17 (02): : 169 - 170
  • [40] Optimizing adherence and persistence to non-vitamin K antagonist oral anticoagulant therapy in atrial fibrillation
    Farinha, Jose Maria
    Jones, Ian D.
    Lip, Gregory Y. H.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24 : A42 - A55
12345